The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease

Catalano, Mariella; Cortelazzo, Adriano; YILMAZ, YUSUF; Perilli, Edoardo; Carzaniga, Gianni; Emanuele, Enzo

doi:10.1016/j.cca.2007.09.014

The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease

Catalano M., Cortelazzo A., YILMAZ Y., Perilli E., Carzaniga G., Emanuele E.

CLINICA CHIMICA ACTA, cilt.387, ss.109-112, 2008 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 387
Basım Tarihi: 2008
Doi Numarası: 10.1016/j.cca.2007.09.014
Dergi Adı: CLINICA CHIMICA ACTA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.109-112
Bursa Uludağ Üniversitesi Adresli: Hayır

Özet

Background: Plasma lipoprotein(a) [Lp(a)] levels are mainly genetically determined. The C93T polymorphism is a naturally occurring variant of the LPA gene that may influence Lp(a) concentration. The role of Lp(a) in the pathogenesis of peripheral arterial disease (PAD) has not been firmly established.